With the growing use of innovative technologies in the health care sector, global telemedicine market value is set to increase substantially. The concept of remote patient monitoring is gaining traction broadly among medical professionals and patients alike due to the convenience it offers for diagnosis and treatment. During the COVID-19 pandemic, there was a significant uptake in the demand for telemedicine solutions caused by patient cancellations of in-person appointments during the rapid spread of the virus. Across the world, hospitals and clinics switched to videoconferencing for appointments to discuss diagnosis and treatment options with patients for non-critical cases. According to a report by the Department of Health and Human Services, the number of medical visits carried out via telehealth grew from 840,000 in 2019 to 52.7 million in 2020,1 which was a 63-fold increase.

Qiuchong Chen,1,* Yixue Zhang,1,* Mengjun Zhang,1 Ziying Li,1 Jindong Liu1,2 1Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China; 2Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, People's Republic of China *These authors contributed equally to this work Correspondence: Jindong Liu, Department of Anesthesiology, The Affiliated Hospital of Xuzhou Medical University, 99 Huaihai Road West, Quanshan District, Xuzhou, Jiangsu, 221000, People's Republic of China, Email [email protected] Objective: There has been a worldwide increment in acute kidney injury (AKI) incidence among elderly orthopedic operative patients. The AKI prediction model provides patients' early detection a possibility at risk of AKI; most of the AKI prediction models derive, however, from the cardiothoracic operation. The purpose of this study is to predict the risk of AKI in elderly patients after orthopedic surgery based on machine learning algorithm models. Methods: We organized a retrospective study being comprised of 1000 patients with postoperative AKI undergoing orthopedic surgery from September 2016, to June, 2021. They were divided into training (80%;n 799) and test (20%;n 201) sets.We utilized nine machine learning (ML) algorithms and used intraoperative information and preoperative clinical features to acquire models to predict AKI. The performance of the model was evaluated according to the area under the receiver operating characteristic (AUC), sensitivity, specificity and accuracy. Select the optimal model and establish the nomogram to make the prediction model visualization. The concordance statistic (C-statistic) and calibration curve were used to discriminate and calibrate the nomogram respectively. Results: In predicting AKI, nine ML algorithms posted AUC of 0.656– 1.000 in the training cohort, with the randomforest standing out and AUC of 0.674– 0.821 in the test cohort, with the logistic regression model standing out.

Cleaning robot'Franzi' cleans in the entrance area of a hospital in Munich Neuperlach, southern Germany, on February 12, 2021. Every time someone mentions robots, I think of my grandmother. At 93, she was almost completely blind, in a wheelchair, and living in a nursing home. She was wheeled each morning into a room where a volunteer read the local newspaper. On my rare visits (I lived several states away), it was not uncommon for me to enter that room and find all the residents sleeping.

With the ever-increasing volume, variety, and velocity of available data, scientific disciplines have provided us with advanced mathematical tools, processes, and algorithms enabling us to use this data in meaningful ways. Data science (DS), machine learning (ML), and artificial intelligence (AI) are three such disciplines. A question that frequently comes up in many data-related discussions is what the difference between DS, ML, and AI is? Can they be compared? Depending on who you talk to, how many years of experience they have had, and what projects they have worked on, you may get widely different answers to the above question. In this blog, I will attempt to answer this based on my research, academic, and industry experience; and having facilitated numerous conversations on the topic.

The lack of representative coronavirus disease 2019 (COVID-19) data is a bottleneck for reliable and generalizable machine learning. Data sharing is insufficient without data quality, in which source variability plays an important role. We showcase and discuss potential biases from data source variability for COVID-19 machine learning. We used the publicly available nCov2019 dataset, including patient-level data from several countries. We aimed to the discovery and classification of severity subgroups using symptoms and comorbidities. Cases from the 2 countries with the highest prevalence were divided into separate subgroups with distinct severity manifestations.

Clare Medical's AI-based diagnostic tool reduced the need for admissions and other interventions by ... [ ] over 50% in clinical trials. An artificial intelligence-based diagnostic tool has reduced hospital admissions by 51% among at-risk elderly patients, according to results of a trial released by the tool's manufacturer, the health care provider Clare Medical. Announcing the results of its trial on Wednesday, Clare Medical concluded that predicting which patients have a higher probability of experiencing medical "events" significantly reduces the probability of such events occurring. This is because its AI-based tool provides clinicians with the opportunity for early intervention. The trial found that the use of AI-based diagnostics has significantly positive outcomes with respect to reducing a patient's risk of requiring a hospital visit within 30 days.

Clare Medical's AI-based diagnostic tool reduced the need for admissions and other interventions by ... [ ] over 50% in clinical trials. An artificial intelligence-based diagnostic tool has reduced hospital admissions by 51% among at-risk elderly patients, according to results of a trial released by health care provider Clare Medical. Announcing the results of its trial on Wednesday, Clare Medical concluded that predicting which patients have a higher probability of experiencing medical "events" significantly reduces the probability of such events occurring. This is because its AI-based tool provides clinicians with the opportunity for early intervention. The trial found that the use of AI-based diagnostics has significantly positive outcomes with respect to reducing a patient's risk of requiring a hospital visit within 30 days.

An artificial intelligence-based diagnostic tool has reduced hospital admissions by 51% among at-risk elderly patients, according to results of a trial released by health care provider Clare Medical. Announcing the results of its trial on Wednesday, Clare Medical concluded that predicting which patients have a higher probability of experiencing medical "events" significantly reduces the probability of such events occurring. This is because its AI-based tool provides clinicians with the opportunity for early intervention. The trial found that the use of AI-based diagnostics has significantly positive outcomes with respect to reducing a patient's risk of requiring a hospital visit within 30 days. At a time when the coronavirus pandemic is placing significant strain on the world's health systems, such outcomes could end up saving substantial amounts of time and money for hospitals, not to mention the benefits for patients themselves.

Robotics is increasingly being considered synonymous with progress within multiple industries. Healthcare robotics has been specifically developed to improve patient outcomes. Healthcare robotics varies, as there are multiple ways they can be used in a healthcare setting. The industry is expanding with the adoption of automation across all areas. Surgical robotic systems are a paragon of robotics in the medtech industry.

With the ever-increasing volume, variety, and velocity of available data, scientific disciplines have provided us with advanced mathematical tools, processes, and algorithms enabling us to use this data in meaningful ways. Data science (DS), machine learning (ML), and artificial intelligence (AI) are three such disciplines. A question that frequently comes up in many data-related discussions is what the difference between DS, ML, and AI is? Can they even be compared? Depending on who you talk to, how many years of experience they have had, and what projects they have worked on, you may get widely different answers to the above question. In this blog, I will attempt to answer this based on my research, academic, and industry experience; and having facilitated numerous conversations on the topic.